Moberg Pharma
6,3 SEK -0,79 %Vær den første som følger denne virksomhed
Moberg Pharma is a Swedish pharmaceutical company focused on the commercialization of proprietary medicines based on proven substances. The company mainly works in nail fungus, where Moberg Pharma is developing a new external treatment. The company has agreements with commercial partners on site in Europe and Asia, among other places. The head office is in Bromma.
Omsætning
207 t
EBIT %
-9.772,95 %
P/E
-
Udbytteafkast, %
-
Kursmål
-
Anbefaling
-
Opdateret
-
NASDAQ Stockholm
MOB
Daglig lav / høj pris
6,2 / 6,65
SEK
Markedsværdi
178,97 mio. SEK
Aktieomsætning
2,29 mio. SEK
Volumen
360 t
Finanskalender
Ekstraordinær generalforsamling
09.10.2023
Delårsrapport
07.11.2023
Årsrapport
13.02.2024
Delårsrapport
07.05.2024
Delårsrapport
17.08.2024
Major OwnersSource: Millistream Market Data AB
| Owner | Capital | Votes |
|---|---|---|
| Östersjöstiftelsen | 9,8 % | 9,8 % |
| Avanza Pension | 7,2 % | 7,2 % |
Premium
Not activated
This content is for our Premium customers only.
Viser Alle indholdstyper